Journal profile · Clinical Neurology
Journal of Neuro-Oncology
ISSN 0167-594X · eISSN 1573-7373 · Springer US · UNITED STATES · Monthly · Founded 1983
Journal of Neuro-Oncology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.43; hybrid open access; APC about USD 4,590; median 39 days to acceptance (123 articles, last 24 months); community-reported acceptance: about 75%; 471 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Neuro-Oncology is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Brain Metastases and Treatment and Meningioma and schwannoma management, together about 59.3% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neuroradiologists, neuropsychologists, palliative care specialists, and laboratory-based oncologists conducting relevant research. The journal encompasses research related to adult and/or pediatric neuro-oncology. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found. Editor Emeritus: Joseph Piepmeier, MD, Yale University, New Haven, Connecticut, USA Linda M. Liau, MD, PhD, MBA, University of California at Los Angeles, Los Angeles, California, USA
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Jason P. SheehanPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 52, Netherlands 4, Italy 3, Canada 3, United Kingdom 2 (79 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine32.9%
- Brain Metastases and TreatmentMedicine15.6%
- Meningioma and schwannoma managementMedicine10.8%
- Neurofibromatosis and Schwannoma CasesMedicine3.8%
- Neuroblastoma Research and TreatmentsMedicine3.6%
- Lung Cancer Research StudiesMedicine2.9%
- Pituitary Gland Disorders and TreatmentsMedicine2.7%
- Management of metastatic bone diseaseMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.43LetPub ·
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- SJR 2026-06
- 1.03LetPub ·
- SNIP 2026-06
- 1.04LetPub ·
- h-index
- 105LetPub ·
- h-index
- 166OpenAlex ·
- i10-index
- 6,487OpenAlex ·
- 2-year mean citedness
- 3.07OpenAlex ·
- Self-citation rate
- 8.8%LetPub ·
- Share of gold OA articles
- 38.69%LetPub ·
Volume
- Articles per year
- 436LetPub ·
- Downloads per year (publisher) 2025
- 1,700,000Publisher website ·
Articles by year OpenAlex count · 9,662 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 426 | 203 | 172 |
| 2025 | 471 | 206 | 1,198 |
| 2024 | 372 | 185 | 2,532 |
| 2023 | 314 | 127 | 3,100 |
| 2022 | 306 | 107 | 4,304 |
| 2021 | 261 | 117 | 5,371 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
39 daysMedian, submission to acceptance · P25–P75 31 days – 56 days
- Acceptance to online
- median 12 days (123 articles)
- Submission to online
- median 58 days
- Sample
- 123 articles with submission and acceptance dates (974 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3.3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
- Connectomics in Neuro-oncologyDeadline
- Biomarkers for GliomasDeadline
What to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted13
- case reportThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- case studyThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- commentsComments (formerly Letters to the Editor) Manuscript body text is limited to 750 words.Length not stated
- editorialThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- letters to the editorThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- original researchThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- priority reportOriginal Laboratory Investigations and Clinical Studies of unusually high impact and timely findings in the field may be submitted as a “Priority Report” for ex…Length not stated
- researchResearch (formerly Laboratory Investigations) Comprehensive scientific reports of original laboratory research.Length not stated
- research articleThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- reviewThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- review articleThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
- reviewsReviews (formerly Topic Reviews) Review articles are usually solicited by the editors, but we will consider unsolicited topic reviews of merit.Length not stated
- systematic reviewThe Journal welcomes original reports dealing with both Research articles and Case Studies (formerly known as Laboratory Investigations and Clinical Studies) re…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
ORCID required for corresponding author before submission Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Optional data availability statement encouraged Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permission required for previously published material Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Neuro-Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Authors may suggest or exclude reviewers Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1983
- ISSN
- 0167-594X
- Electronic ISSN
- 1573-7373
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Neuro-Oncology
What CAS zone is Journal of Neuro-Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Neuro-Oncology is in Zone 2 of Medicine, and in Zone 3 of the minor category Clinical Neurology / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Neuro-Oncology?
The latest impact factor listed by LetPub is 3.43; CiteScore 5.5, h-index 166.
How long does peer review take at Journal of Neuro-Oncology?
Based on the dates recorded on 123 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 39 days (interquartile range 31–56 days); authors report an average review time of about 3.3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Neuro-Oncology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Neuro-Oncology based?
Of the 79 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (52), Netherlands (4) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Neuro-Oncology?
According to LetPub and DOAJ records, Journal of Neuro-Oncology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Neuro-Oncology open access, and what is the APC?
Journal of Neuro-Oncology is a hybrid journal. For open-access publication: APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .